Wnt signaling pathway and sclerostin in the development of atherosclerosis and vascular calcification

被引:3
作者
Kocelak, Piotr [1 ]
Puzianowska-Kuznicka, Monika [2 ,3 ]
Olszanecka-Glinianowicz, Magdalena [4 ]
Chudek, Jerzy [5 ]
机构
[1] Med Univ Silesia, Fac Med Sci, Dept Pathophysiol, Pathophysiol Unit, Katowice, Poland
[2] Med Ctr Postgrad Educ, Dept Geriatr & Gerontol, Warsaw, Poland
[3] Polish Acad Sci, Mossakowski Med Res Inst, Dept Human Epigenet, PL-02106 Warsaw, Poland
[4] Med Univ Silesiaia, Fac Med Sci Katowice, Dept Pathophysiol, Hlth Promot & Obes Management Unit, PL-40055 Katowice, Poland
[5] Med Univ Silesia, Fac Med Sci Katowice, Dept Internal Med & Oncol Chemotherapy, Katowice, Poland
来源
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE | 2024年 / 33卷 / 05期
关键词
atherosclerosis; aneurysm; cardiovascular disease; sclerostin; WNT-signaling; SMOOTH-MUSCLE-CELLS; BONE-MINERAL DENSITY; WNT/BETA-CATENIN; POSTMENOPAUSAL WOMEN; SERUM SCLEROSTIN; CIRCULATING SCLEROSTIN; AORTIC-ANEURYSM; KIDNEY-DISEASE; OSTEOBLAST DIFFERENTIATION; CONVERGENT EXTENSION;
D O I
10.17219/acem/169567
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Atherosclerosis is a complex process involving endothelial dysfunction, vascular inflammation, vascular smooth muscle cell (VSMC) proliferation, angiogenesis, and calcification. One of the pathomechanisms of atherosclerosis is the upregulation of Wnt signaling. This study aimed to summarize the current knowledge regarding the role of Wnt signaling and sclerostin in atherosclerosis, vascular calcification, aneurysms, and mortality based on the PubMed database. We followed the Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) recommendation and identified 160 papers that were included in this systematic review. The published data highlight that the upregulation of Wnt components facilitates the initiation and progression of atherosclerosis, arterial remodeling, VSMCs proliferation and phenotypic transition to the osteoblastic lineage in the arterial wall. This results in protein secretion, cell migration, calcification, fibrosis and aneurysm formation. The transformation of VSMCs into osteoblast-like cells that is observed in atherosclerosis results in sclerostin expression inhibiting the Wnt pathway. Furthermore, it was shown that sclerostin, expressed in atherosclerotic plaques, inhibits aneurysm formation in a mouse model. However, in humans, while the antisclerostin antibody romosozumab inhibits bone resorption, biochemical parameters of endothelial activation and inflammation are not affected, and the incidence of aneurysms is not increased. It was suggested that detecting sclerostin in the calcified aortic atherosclerotic plaques reflects a defense mechanism against Wnt activation and inhibition of atherosclerosis, although this has only been shown in animal models. Moreover, an increased number of vascular cells converted to osteogenic phenotypes results in increased plasma sclerostin concentrations. Therefore, plasma sclerostin derived from bone limits its importance as a global marker of vascular calcification.
引用
收藏
页码:519 / 532
页数:14
相关论文
共 50 条
  • [1] The Wnt/β-catenin Signalling Pathway Inhibitor Sclerostin is a Biomarker for Early Atherosclerosis in Obesity
    Popovic, Djordje S.
    Mitrovic, Milena
    Tomic-Naglic, Dragana
    Icin, Tijana
    Bajkin, Ivana
    Vukovic, Bojan
    Benc, Damir
    Zivanovic, Zeljko
    Kovacev-Zavisic, Branka
    Stokic, Edita
    CURRENT NEUROVASCULAR RESEARCH, 2017, 14 (03) : 200 - 206
  • [2] The Interplay of WNT and PPARγ Signaling in Vascular Calcification
    Reinhold, Stefan
    Blankesteijn, W. Matthijs
    Foulquier, Sebastien
    CELLS, 2020, 9 (12) : 1 - 27
  • [3] Serum sclerostin in vascular calcification and clinical outcome in chronic kidney disease
    Zeng, Cong
    Guo, Chunyuan
    Cai, Juan
    Tang, Chengyuan
    Dong, Zheng
    DIABETES & VASCULAR DISEASE RESEARCH, 2018, 15 (02) : 99 - 105
  • [4] Wnt Signaling in Vascular Calcification
    Bundy, Kaylee
    Boone, Jada
    Simpson, C. LaShan
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [5] Wnt Signaling Pathway Inhibitor Sclerostin Inhibits Angiotensin II-Induced Aortic Aneurysm and Atherosclerosis
    Krishna, Smriti Murali
    Seto, Sai-Wang
    Jose, Roby J.
    Li, Jiaze
    Morton, Susan K.
    Biros, Erik
    Wang, Yutang
    Nsengiyumva, Vianne
    Lindeman, Jan H. N.
    Loots, Gabriela G.
    Rush, Catherine M.
    Craig, Jeffrey M.
    Golledge, Jonathan
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37 (03) : 553 - +
  • [6] Atherosclerosis, vascular calcification and osteoporosis
    Valero, Carmen
    Macias, Jesus Gonzalez
    MEDICINA CLINICA, 2025, 164 (04): : e13 - e20
  • [7] The Role of Wnt Signaling and Sclerostin in the Pathogenesis of Glucocorticoid-Induced Osteoporosis
    Guanabens, Nuria
    Gifre, Laia
    Peris, Pilar
    CURRENT OSTEOPOROSIS REPORTS, 2014, 12 (01) : 90 - 97
  • [8] The Interplay of SIRT1 and Wnt Signaling in Vascular Calcification
    Bartoli-Leonard, Francesca
    Wilkinson, Fiona L.
    Langford-Smith, Alex W. W.
    Alexander, M. Y.
    Weston, Ria
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2018, 5
  • [9] Sclerostin Protects Against Vascular Calcification Development in Mice
    De Mare, Annelies
    Opdebeeck, Britt
    Neven, Ellen
    D'Haese, Patrick C.
    Verhulst, Anja
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 (04) : 687 - 699
  • [10] Sclerostin, Osteocytes, and Wnt Signaling in Pediatric Renal Osteodystrophy
    Laster, Marciana
    Pereira, Renata C.
    Noche, Kathleen
    Gales, Barbara
    Salusky, Isidro B.
    Albrecht, Lauren V.
    NUTRIENTS, 2023, 15 (19)